Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Palo Alto Investors and Alimera Sciences Inc (ALIM)

Page 1 of 11

Alimera Sciences Inc (NASDAQ:ALIM): William Leland Edwards’ Palo Alto Investors filed an amended 13D.

You can check out Palo Alto Investors’ latest holdings and filings here.

Please follow Palo Alto Investors (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Palo Alto Investors or update its stock holdings.

William Leland Edwards
William Leland Edwards
Palo Alto Investors

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Patrick Lee, MD 0 12,036,349 0 12,036,349 12,036,349 17.43%
Anthony Joonkyoo Yun, MD 0 12,036,349 0 12,036,349 12,036,349 17.43%
Palo Alto Investors 0 12,036,349 0 12,036,349 12,036,349 17.43%
Palo Alto Healthcare Master Fund 0 4,693,255 0 4,693,255 4,693,255 6.80%
Palo Alto Healthcare Master Fund II 0 6,890,786 0 6,890,786 6,890,786 9.98%
William Leland Edwards
William Leland Edwards
Palo Alto Investors

Page 1 of 11 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 8)

Alimera Sciences, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

016259103

(CUSIP Number)

October 2, 2017

(Date of Event Which Requires Filing of this
Statement)

Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:

[X] Rule 13d-1(b)

[ ] Rule 13d-1(c)

[ ] Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or
otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

Potential persons who are to respond to the collection of information
contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1
Follow Alimera Sciences Inc (NASDAQ:ALIM)
Trade (NASDAQ:ALIM) Now!
Page 1 of 11
Loading...